Evidence map›Paper›PMID 40390080›Full record

ArticleBMC research notes2025

Analysis of cardiovascular and cerebral disease risk trends before and during the COVID-19 transition phase in Golestan province.

Mohammad-Ali Jahani, Somayeh Safaie, Mansooreh Gharayagh-Zandi, Seyed-Amir Soltani, Seyedeh-Nikoo Hashemi, Amir-Reza Mahmoudi, Ghahraman Mahmoudi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammad-Ali JahaniSocial Determinants of Health Research Center Health Research Institute, Babol University of Medical Sciences, Babol, I. R. of Iran.
Somayeh SafaieMaster of Science of Healthcare Services Management, Golestan University of Medical Sciences, Gorgan, I. R. of Iran.
Mansooreh Gharayagh-ZandiHospital Administration Research Center, Sari Branch, Islamic Azad University, Sari, IR, I. R. of Iran.
Seyed-Amir SoltaniHospital Administration Research Center, Sari Branch, Islamic Azad University, Sari, IR, I. R. of Iran.
Seyedeh-Nikoo HashemiDoctorate of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Amir-Reza MahmoudiDoctorate of Medicine Candidate Hospital Administration Research Center, Sari Branch, Islamic Azad University, Sari, I. R. of Iran.
Ghahraman MahmoudiHospital Administration Research Center, Sari Branch, Islamic Azad University, Sari, I. R. of Iran. Ghahraman48@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMorbidity and mortality caused by cardiovascular and cerebrovascular diseases are increasing worldwide. This study aimed to analyze the factors affecting the risk assessment of cardiovascular and cerebrovascular diseases before COVID-19 and during the COVID-19 transition phase.

resultsAmong 132,305 individuals (mean age: 50.11 ± 12.21 years), 65.84% were women. Regression analysis indicated that age, overweight, smoking, diabetes, hypertension, and high cholesterol significantly increased 10-year cardiovascular disease risk (p < 0.001). No significant trend in risk levels was found between pre-COVID-19 and COVID-19 transition periods (p = 0.063). Given the impact of these factors, national-level planning, appropriate policies, and intersectoral coordination are essential to reduce cardiovascular and cerebrovascular risk.

Indexed as

Cardiovascular DiseasesCerebrovascular DisordersCOVID-19AdultAgedFemaleHumansHypertensionMaleMiddle AgedRisk AssessmentRisk FactorsSARS-CoV-2Cardiovascular diseasesNon-infectiousPatientsRisk assessment

Identifiers

PMID40390080
PMCPMC12087107

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.